Clinical Trial Update: Alprostadil as an Adjuvant Therapy With Indirect Angiosomal Revascularization in Critical Limb Ischemia. [Phase 4]

View source ↗

Summary

Trial update for alprostadil as an adjuvant therapy in critical limb ischemia (Phase 4).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia

Drugs mentioned

• ALPROSTADIL (ALPROSTADIL)

Snippet

Sponsor: Assiut University | Conditions: Critical Limb Ischemia | Phase 4 | Status: UNKNOWN